Home » Topics » BioWorld Science

BioWorld Science
RSS

DRA inhibitors synthesized for cystic fibrosis-related nephrolithiasis

Nov. 18, 2019

First-in-human data presented for tetrameric bispecific antibody AK-104

Nov. 18, 2019

Results presented from proof-of-concept phase I study of cenerimod

Nov. 18, 2019

Positive results presented from second phase III psoriasis study of bimekizumab

Nov. 18, 2019

Anchiano discontinues phase II Codex study of inodiftagene vixteplasmid in NMIBC

Nov. 18, 2019

New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs

Nov. 18, 2019

New Smo antagonist shows antitumor activity in medulloblastoma and cholangiocarcinoma animal models

Nov. 18, 2019

HPN-328 targeting DLL3 shows preclinical efficacy and safety for immunotherapy in SCLC

Nov. 18, 2019

Roche presents first-in-human data for RO-7062931

Nov. 18, 2019

resTORbio stops development of RTB-101 for clinically symptomatic respiratory illness

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...